Companies /Healthcare

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ: LMRI Medical Devices
$10.81
▲ $0.13 (+1.22%) today
Markets closed · 5:11pm ET

LMRI at a Glance

Valuation
Market cap
$1.0B
Profitability
Revenue (TTM)
$1.0B
Profit margin
-2.7%
EPS (TTM)
$-0.37
Price
52-week range
$6 – $19
Street target
$17.67

Headquartered in Raleigh, NC Fiscal year ends December NASDAQ: LMRI lumexaimaging.com

About Lumexa Imaging Holdings

Lumexa Imaging is a nationwide provider of outpatient medical imaging services in the United States. The company operates over 190 outpatient imaging centers, including 104 consolidated centers and 88 joint venture centers, with more than 5,000 team members. It conducted approximately 4 million outpatient procedures system-wide in 2025. Lumexa Imaging partners with health systems and radiologists to deliver clinical imaging services, with a growing focus on advanced imaging modalities such as MRI and CT. The company generates revenue through net patient service fees from its consolidated centers and management fees from joint-ventured outpatient sites. It currently has nine health system partnerships, including a recent joint venture with Hospital for Special Surgery (HSS). The company operates through two reportable segments: Outpatient and Professional. Updated

LMRI Coverage

Frequently Asked Questions

What does Lumexa Imaging Holdings do?

Lumexa Imaging is a nationwide provider of outpatient medical imaging services in the United States. The company operates over 190 outpatient imaging centers, including 104 consolidated centers and 88 joint venture centers, with more than 5,000 team members.

What is the LMRI stock price target?

The Wall Street consensus 12-month price target for LMRI is $17.67.